Saitama, Japan

Kenichi Shikada


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenichi Shikada: Innovator in Pharmaceutical Chemistry

Introduction

Kenichi Shikada is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly with a focus on innovative chemical compounds. His inventive prowess is highlighted by his patent, which addresses an important area in medical science.

Latest Patents

Shikada holds a patent for his invention titled "3(2H)pyridazinones for antagonistic agent against SRS-A." This patent involves a novel 3(2H)pyridazinone formula characterized by various groups that can be hydrogen, alkyl, halogen, nitro, or amino among others. The invention offers potential therapeutic benefits, making important strides in the development of anti-allergic medications.

Career Highlights

Kenichi Shikada is associated with Nissan Chemical Industries Limited, an esteemed company known for its advancements in chemical products and solutions. His role in the organization underscores his commitment to innovation within the pharmaceutical sector.

Collaborations

In his career, Shikada has worked alongside talented colleagues such as Keizo Tanikawa and Ryozo Saloda. Their collaborative efforts have undoubtedly contributed to the innovative environment, fostering developments that push the boundaries of pharmaceutical research.

Conclusion

Kenichi Shikada exemplifies the spirit of innovation through his dedication to pharmaceutical chemistry. His patent represents a meaningful contribution to medical science, and his collaborations within Nissan Chemical Industries Limited highlight the importance of teamwork in driving advancements. As he continues his work, Shikada remains a significant figure in the realm of chemical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…